GleamWall
中文EN

APYX Apyx Medical Corp

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 719135 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY24.4%
TTM net income YoY42.0%
TTM EPS YoY—
Revenue 3-yr CAGR5.8%
Net income 3-yr CAGR—

Margins

Gross margin63.4%
Operating margin-5.5%
Net margin-14.2%
FCF margin-14.9%
EBITDA margin-4.1%

Returns

ROE-109.0%
ROA-14.2%
ROIC (approx.)-14.9%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets83.7%
Debt / equity3.69x
Current ratio4.95x
Interest coverage-0.59x

Cash quality & payout

Operating cash flow / net income0.98x
Accruals ratio-0.4%
Payout ratio—
Capex / revenue1.1%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$14.03M$13.88M$12.49M$19.16M$12.88M$11.37M$9.43M$14.22M
Cost of revenue$5.03M$5.01M$4.57M$7.17M$4.58M$4.29M$3.77M$5.26M
Gross profit$9.00M$8.87M$7.92M$12.00M$8.30M$7.08M$5.67M$8.96M
R&D expense$849,000$793,000$765,000$944,000$801,000$824,000$804,000$1.12M
SG&A expense$3.98M$5.29M$3.58M$4.62M$3.82M$4.26M$3.47M$4.83M
Operating income-$571,000-$1.81M-$911,000$11,000-$832,000-$2.57M-$3.05M-$3.05M
Interest expense$1.41M$1.39M$1.37M$1.41M$1.41M$1.39M$1.38M$1.65M
Pretax income-$1.69M-$2.95M-$2.00M-$1.15M-$1.88M-$3.69M-$4.12M-$4.57M
Income tax$116,000$124,000$143,000$94,000$78,000$49,000$49,000$89,000
Net income-$1.78M-$3.24M-$2.11M-$1.30M-$1.98M-$3.78M-$4.15M-$4.63M
EBITDA-$384,000-$1.61M-$709,000$232,000-$668,000-$2.44M-$2.91M-$2.91M
EPS (basic)-0.04-0.07-0.05—-0.05-0.09-0.10—
EPS (diluted)————————
Balance sheet
Cash & equivalents$25.78M$27.62M$31.14M$31.74M$25.14M$29.30M$31.01M$31.74M
Receivables$14.87M$13.61M$12.76M$16.78M$12.99M$11.25M$11.64M$15.48M
Inventory$11.95M$10.75M$9.54M$8.60M$9.14M$8.19M$7.68M$7.56M
Current assets$53.84M$53.16M$54.80M$58.47M$48.79M$49.91M$51.85M$56.44M
PP&E, net$2.19M$2.11M$2.23M$2.37M$2.39M$2.05M$1.91M$1.99M
Total assets$61.67M$61.07M$63.02M$66.84M$57.37M$58.19M$60.16M$64.84M
Current liabilities$10.87M$9.35M$9.45M$11.70M$10.98M$10.57M$9.51M$10.72M
Long-term debt$35.57M$35.33M$35.09M$34.85M$34.61M$34.37M$34.13M$33.89M
Total debt$35.57M$35.33M$35.09M$34.85M$34.61M$34.37M$34.13M$33.89M
Total liabilities$51.63M$49.98M$49.94M$52.01M$51.28M$50.73M$49.52M$50.51M
Shareholders' equity$9.63M$10.66M$12.83M$14.54M$5.85M$7.25M$10.51M$14.21M
Net debt$9.80M$7.71M$3.95M$3.11M$9.47M$5.06M$3.12M$2.15M
Shares outstanding42.12M42.12M41.87M41.79M37.82M37.79M37.79M37.79M
Cash flow statement
Operating cash flow-$1.63M-$3.49M-$572,000-$2.53M-$3.54M-$1.23M-$702,000-$2.94M
Capital expenditure$265,000$66,000$60,000$275,000$519,000$265,000$55,000$245,000
Free cash flow-$1.90M-$3.56M-$632,000-$2.81M-$4.05M-$1.50M-$757,000-$3.18M
Investing cash flow-$265,000-$66,000-$60,000-$275,000-$519,000-$265,000-$55,000-$245,000
Financing cash flow-$5,000-$5,000$83,000$9.48M$45,000$25,000$25,000$6.76M
Depreciation & amortization$187,000$196,000$202,000$221,000$164,000$132,000$138,000$142,000
Stock-based compensation$753,000$1.07M$312,000$500,000$530,000$520,000$451,000$838,000

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.